Infant Bacterial Therapeutics AB (publ)

SSE:IBT-B.ST

93.4 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

20232022202120202019201820172016201520142012
Operating Activities:
Net Income -123.068-65.808-44.578-71.918-47.2-39.417-36.141-38.09-20.615-6.592-0.002
Depreciation & Amortization 0.8160.8160.8160.8160.8160.8160.8160.811000
Deferred Income Tax 00000000000
Stock Based Compensation 00000000000
Change In Working Capital 18.95911.847.398-2.323-1.4781.1340.577-2.4533.62.9750
Accounts Receivables -9.3087.1514.338-4.611-2.71.133-1.1930.578-0.62800
Inventory -28.267-4.689000000000
Accounts Payables 28.2674.68900001.77-3.031000
Other Working Capital 28.2674.6893.062.2881.2220.0011.77-3.0314.22800
Other Non Cash Items 2.074-32.643-19.25915.036-3.439-9.942-0.015-0.016-0.009-0.1550.002
Operating Cash Flow -101.219-85.795-55.623-58.389-51.301-47.409-34.763-39.748-17.024-3.7720
Investing Activities:
Investments In Property Plant And Equipment 000000-0.050-10.1500
Acquisitions Net 000000-0.050000
Purchases Of Investments 00000000000
Sales Maturities Of Investments 00000000000
Other Investing Activites 0-0.001000000-10.15-6.0750
Investing Cash Flow -4.146-0.0010000-0.050-10.15-6.0750
Financing Activities:
Debt Repayment 00000000000
Common Stock Issued 96.5151.9040.0911.7640439.14299.30189.123000
Common Stock Repurchased 0-0.02000000000
Dividends Paid 00000000000
Other Financing Activities 96.515-0.020.0911.7640-10.18999.30189.12370.531100
Financing Cash Flow 96.5151.8840.0911.7640428.95399.30189.12370.531100
Other Information:
Effect Of Forex Changes On Cash 2.0743318.846-15.1254.3192.35200000
Net Change In Cash -6.776-50.912-36.686-71.75-46.982383.89664.48849.37543.3570.1530
Cash At End Of Period 329.064335.84386.752423.438495.188542.17158.27493.78644.4111.0540